Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/1312
Title: A pilot study of the comparative efficacy of 100 Hz magnetic seizure therapy and electroconvulsive therapy in persistent depression
Epworth Authors: Fitzgerald, P.B.
Chen, L.
Other Authors: Hoy, K.E.
Elliot, D.
McQueen, S.
Wambeek, L.E.
Clinton, A.M.
Downey, G.
Daskalakis, Z.J.
Keywords: ECT
Magnetic Seizure Therapy
MST
Therapeutic Seizures
Transcranial Magnetic Stimulation
Electroconvulsive Therapy
ECT
Brain Stimulation
Depression
Antidepressants
Rehabilitation, Mental Health and Chronic Pain Clinical Institute, Epworth HealthCare, Victoria, Australia
Issue Date: May-2018
Publisher: Wiley
Citation: Depress Anxiety. 2018 May;35(5):393-401
Abstract: BACKGROUND: Magnetic seizure therapy (MST) is a novel brain stimulation technique that uses a high-powered transcranial magnetic stimulation device to produce therapeutic seizures. Preliminary MST studies have found antidepressant effects in the absence of cognitive side effects but its efficacy compared to electroconvulsive therapy (ECT) remains unclear. The aim of this study was to investigate the therapeutic efficacy and cognitive profile of MST compared to standard right unilateral ECT treatment. METHODS: Thirty-seven patients completed a course of at least nine ECT or MST treatments in a randomized double-blind protocol. Assessments of depression severity and cognition were performed before and after treatment. RESULTS: No difference in the antidepressant effectiveness between the treatments was seen across any of the clinical outcome measures, although the overall response rates in both groups were quite low. In regards to cognition, following MST there were significant improvements in tests of psychomotor speed, verbal memory, and cognitive inhibition, with no reductions in cognitive performance. Following ECT there was significant improvement in only one of the cognitive inhibition tasks. With respect to the between-group comparisons, the MST group showed a significantly greater improvement on psychomotor speed than ECT. CONCLUSIONS: MST showed similar efficacy to right unilateral ECT in patients with treatment-resistant depression without cognitive side effects but in a sample that was only of sufficient size to demonstrate relatively large differences in response between the two groups. Future research should aim to optimize the methods of MST administration and compare its efficacy to ECT in large randomized controlled trials.
URI: http://hdl.handle.net/11434/1312
DOI: https://doi.org/10.1002/da.22715
PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/29329499
ISSN: 1091-4269
1520-6394
Journal Title: Depression and Anxiety
Type: Journal Article
Affiliated Organisations: Monash Alfred Psychiatry Research Centre, Monash University Central Clinical School, Melbourne, VIC, Australia
Department of Psychiatry, The Alfred Hospital, Melbourne, VIC, Australia
Department of Anaesthesia and Perioperative Medicine, The Alfred Hospital & Monash University Central Clinical School, Melbourne, VIC, Australia
Department of Psychiatry, Centre for Addiction and Mental Health, University of Toronto, ON, Canada
Type of Clinical Study or Trial: Clinical Trial
Appears in Collections:Mental Health
Neurosciences

Files in This Item:
There are no files associated with this item.


Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.